| Magnetic resonance imaging, referred to as nuclear magnetic resonance,magnetic resonance is a new imaging technique developed in the1980s. Its full nameis: nuclear magnetic resonance computer tomography。It is a new medical imagingtechnology for medical diagnosis. In order to improve the resolution of soft tissue, weused the contrast agent so that part of the incurable diseases to be diagnosed. Theclinical application of contrast agent must meet the following requirements: lowtoxicity, high relaxation efficiency, better water-soluble, with targeted and easilyexcreted in the body stable.Fluorescent molecular markers of Mn3O4nanoparticles have the potential ofmulti-function testing, and magnet-optical dual-function imaging and target effects atthe cellular level. Mn3O4nanoparticles as a T1contrast agent has an advantage inmany ways:(1) high relaxation performance, with positive reinforcement contrasteffects;(2) nanostructures can be extended in vivo circulation time;(3) water-solubleshould be good, through the blood-brain barrier imaging of the brain. Mn3O4nanoparticles contrast agent is not of great significance to the future applicationof the T1nanoparticles contrast agents. Therefore, we synthesized the aptamermodified with multi-function of Mn3O4@SiO2nanoparticles magnet-optical contrastagent through experimental characterization. It showed that the synthesized contrastagent has certain clinical reference value.First, Mn3O4nanoparticles were prepared by hydrolysis, Then TEOS is coatedon the surface of Mn3O4particles through hydrolysis, and then to solve the watersolubility and stability of the Mn3O4nanoparticles, to connect the fluorescent materialoutside of the nanoparticles, The APS is joined on the surface of Mn3O4@SiO2nanoparticles, thereby the nanoparticles surface access large amine, andfinally connect the fluorescent substance: Rhodamine and targeted substances:Aptamers. So Mn3O4@SiO2-NH2(RITC)-Apt nanoparticles are synthesized. Itshowed that the contrast agent with low cytotoxicity in cell, Importantly,Mn3O4@SiO2-NH2(RITC)-Apt nanoparticles have very good enhanced MR imagingresults about HeLa cells. Mn3O4@SiO2-NH2(RITC)-Apt nanoparticles are expected to be used for cancer diagnosis and therapy. |